Bio-Connect

VEGFA antibody

GTX22992
GeneTex
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetVEGFA
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    VEGF antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    Immunohistochemistry (formalin fixed paraffin embedded, rodent tissues only): use at a concentration of 5 - 10microg / ml for 30 min at RT. Staining of formalin fixed tissues requires boiling tissue sections in 10mM Tris-HCl, pH 10.0, for 10 - 20 min followed by cooling at RT for 20 min.Neutralising (Int J Oncology, 8:505-511): assay dependent. Optimal dilutions / concentrations should be determined by the end user. Staining of formalin fixed tissues requires boiling tissue sections in 10mM Tris-HCl, pH 10.0, for 10 - 20 min followed by cooling at RT for 20 min.
  • Applications
    ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.2 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID7422
  • Target name
    VEGFA
  • Target description
    vascular endothelial growth factor A
  • Target synonyms
    MVCD1; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VPF
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP15692
  • Protein Name
    Vascular endothelial growth factor A
  • Scientific Description
    This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. [provided by RefSeq, Nov 2015]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Effects of Ozone on Injury after Gamma Knife Radiosurgery. Emon ST et al., 2021 May, World Neurosurg
    Read more